Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine Immuno Nutrition in Critically Ill Patients
NCT01038622Phase 4Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2009
- Primary completion
- Nov 2010
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of arginine in critical illness, sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2009; status: completed.
02
Drugs
arginine
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT01038622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038622.